Moore, Nicholas

The self-reported Montgomery-Asberg depression rating scale is a useful evaluative tool in major depressive disorder

Fantino, B., & Moore, N. (2009) · BMC Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 200

Benzodiazepines and Injurious Falls in Community Dwelling Elders

Pariente, A., Dartigues, J.-F., Benichou, J., Letenneur, L., Moore, N., & Fourrier-Réglat, A. (2008) · Drugs & Aging

Pharmaceutical Practices and Patient OutcomesBalance, Gait, and Falls Prevention

Cited by 172

Differences between clinical trials and postmarketing use

Martin, K., Bégaud, B., Latry, P., Miremont‐Salamé, G., Fourrier, A., & Moore, N. (2004) · British Journal of Clinical Pharmacology

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical studies and practices

Cited by 157

Liver transplant associated with paracetamol overdose: results from the seven‐country SALT study

Gulmez, S. E., Larrey, D., Pageaux, G., Bernuau, J., Bissoli, F., Horsmans, Y., Thorburn, D., McCormick, P. A., Stricker, B., Toussi, M., et al. (2015) · British Journal of Clinical Pharmacology

Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments

Cited by 99

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies

Salvo, F., Pariente, A., Shakir, S., Robinson, P., Arnaud, M., Thomas, S., Raschi, E., Fourrier‐Réglat, A., Moore, N., Sturkenboom, M., et al. (2016) · Clinical Pharmacology & Therapeutics

Cardiac electrophysiology and arrhythmiasSchizophrenia research and treatment

Cited by 83

Does Ibuprofen Worsen COVID-19?

Moore, N., Carleton, B., Blin, P., Bosco-Levy, P., & Droz, C. (2020) · Drug Safety

COVID-19 Clinical Research StudiesPharmacovigilance and Adverse Drug Reactions

Cited by 78

Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database

Blin, P., Dureau‐Pournin, C., Foubert‐Samier, A., Grolleau, A., Corbillon, E., Jové, J., Lassalle, R., Robinson, P., Poutignat, N., Droz‐Perroteau, C., et al. (2015) · European Journal of Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 74

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)

Thomas, S. H. L., Drici, M. D., Hall, G. C., Crocq, M. A., Everitt, B., Lader, M. H., Jeunne, C. L., Naber, D., Priori, S., Sturkenboom, M., et al. (2010) · Acta Psychiatrica Scandinavica

Schizophrenia research and treatmentPharmacovigilance and Adverse Drug Reactions

Cited by 67

Why are benzodiazepines not yet controlled substances?

Moore, N., Pariente, A., & Bégaud, B. (2015) · JAMA Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 62

Paper OK, title wrong

Moore, N. (2011) · BMJ

Diabetes Treatment and ManagementPharmacovigilance and Adverse Drug Reactions

Cited by 5